Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > most recent target from nasdaq
View:
Post by canadafan on Nov 06, 2024 7:44pm

most recent target from nasdaq

Hello Bucky, agaiin I feel for your complete lack of reading abilities.
Sad actuzlly.
anyhwo to make life easy for you a screen shot from Nasdaq
listed under ONCY ( that being USA dollars)
I uunderstand about $1.29. Would equate to $6.95 CDN.
Im sure you & your bashing crew are well awre of the Nasdaq
going back a few years the consensus was above $8PS. They have come down relating to the alternative market for the MBc applications. 
None of the anlaysts are couting in the Pancreatic cancer. 

Exchange
NASDAQ-CM
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
1 Year Target
$5.00
Today's High/Low
$1.18/$1.105
Share Volume
390,870
Average Volume
470,239
Previous Close
$1.18
52 Week High/Low
$1.75/$0.8401
Market Cap
86,224,357
P/E Ratio
0
Forward P/E 1 Yr.
-4.07
Earnings Per Share(EPS)
$-0.36
 
 
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities